Explore our collection of high-quality research peptides made for performance, recovery, and results
Nobel Prize Outreach 2025
In a cardiovascular outcomes trial, semaglutide treatment increased retinopathy complications
The FDA removed roughly a dozen peptides (including BPC-157 and TB-500) from the restricted list
T2DM patients often suffer from comorbid conditions such as cardiovascular disease, and GLP-1 not only has a good glucose-lowering effect but also has protective effects on the cardiovascular system, kidneys, and other tissues (62, 63)
Bupropion, a dopamine reuptake inhibitor 15 , activates POMC neurons to secrete neurotransmitters that reduce the desire to eat, and naltrexone, an opioid antagonist 15 , blocks the autoinhibitory feedback loop in the hypothalamus to keep POMC neurons activated 58, 59